Work

A Randomized Trial of Rifaximin vs Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel Syndrome

Year: 2026

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2026.04.014

Institutions: University of Michigan, Michigan Medicine, Kaiser Permanente, Trinity Health Ann Arbor Hospital, Mayo Clinic in Arizona

Language: English

Topic: Gastrointestinal motility and disorders

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, University of Michigan, National Institutes of Health, Agency for Healthcare Research and Quality, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Institutional Career Development Core, A Systems Biology Approach Using Fecal Microbiota and Metabolomics to Identify Novel Subtypes in Irritable Bowel Syndrome., G5483833983, G6749908319, G8097333736, The role of sulfidogenic microbes in quiescent Crohn’s disease with persistent symptoms, Michigan Nutrition Obesity Research Center

OpenAlex ID: W7155050277

FWCI:

Cites: 24

Cited by:

Related to: 10